BACKGROUND: Endothelial progenitor cells (EPCs) are attenuated, both in number and functionality, in animal models of chronic cardiovascular and metabolic disorders. This effect has subsequently been linked to the aggravation of long-term morbidity and mortality associated with such disorders. The objective was to examine EPC number and survival in chronic diabetic vs nondiabetic patients in conjunction with the examination of their redox, inflammatory, and antioxidant defense system (Nrf2 genes) status in serum and visceral fat. METHODS: Visceral adipose tissue from diabetic and nondiabetic patients undergoing coronary artery bypass graft surgery was analyzed for Nrf2-dependent genes. Oxidative stress was evaluated using thiobarbituric acid-reactive substance assay (TBARS). Peripheral blood, collected 1 day prior to surgery, was evaluated for inflammatory cytokines and EPCs. RESULTS: When compared with controls (P < 0.05), results of the thiobarbituric acid-reactive substance assay were higher in diabetic patients. Although Nrf2-dependent antioxidant proteins (thioredoxin-1 [Trx-1], nicotinamide adenine dinucleotide phosphate [NAD(P)H] quinone oxidoreductase [NQO1], glutathione S-transferase [GST]) were upregulated, heme oxygenase (HO-1) and adiponectin protein expression were lower in the diabetic group (P < 0.05). Serum levels of bilirubin were lower (P < 0.005) while the levels of inflammatory cytokines were higher in diabetic patients (P < 0.05). EPC levels and their colony forming units were significantly lower (P < 0.05) with reduced viability in diabetic patients as compared with nondiabetic patients. CONCLUSIONS: These results demonstrate for the first time that in diabetic patients, there is an inadequate heme oxygenase-adiponectin axis response, which could compromise the compensatory antioxidant and anti-inflammatory effects consequently contributing toward EPC dysfunction in these patients.
BACKGROUND: Endothelial progenitor cells (EPCs) are attenuated, both in number and functionality, in animal models of chronic cardiovascular and metabolic disorders. This effect has subsequently been linked to the aggravation of long-term morbidity and mortality associated with such disorders. The objective was to examine EPC number and survival in chronic diabetic vs nondiabeticpatients in conjunction with the examination of their redox, inflammatory, and antioxidant defense system (Nrf2 genes) status in serum and visceral fat. METHODS: Visceral adipose tissue from diabetic and nondiabeticpatients undergoing coronary artery bypass graft surgery was analyzed for Nrf2-dependent genes. Oxidative stress was evaluated using thiobarbituric acid-reactive substance assay (TBARS). Peripheral blood, collected 1 day prior to surgery, was evaluated for inflammatory cytokines and EPCs. RESULTS: When compared with controls (P < 0.05), results of the thiobarbituric acid-reactive substance assay were higher in diabeticpatients. Although Nrf2-dependent antioxidant proteins (thioredoxin-1 [Trx-1], nicotinamide adenine dinucleotide phosphate [NAD(P)H] quinone oxidoreductase [NQO1], glutathione S-transferase [GST]) were upregulated, heme oxygenase (HO-1) and adiponectin protein expression were lower in the diabetic group (P < 0.05). Serum levels of bilirubin were lower (P < 0.005) while the levels of inflammatory cytokines were higher in diabeticpatients (P < 0.05). EPC levels and their colony forming units were significantly lower (P < 0.05) with reduced viability in diabeticpatients as compared with nondiabeticpatients. CONCLUSIONS: These results demonstrate for the first time that in diabeticpatients, there is an inadequate heme oxygenase-adiponectin axis response, which could compromise the compensatory antioxidant and anti-inflammatory effects consequently contributing toward EPC dysfunction in these patients.
Authors: Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner Journal: Circulation Date: 2002-11-26 Impact factor: 29.690
Authors: Sajoscha A Sorrentino; Ferdinand H Bahlmann; Christian Besler; Maja Müller; Svenja Schulz; Nina Kirchhoff; Carola Doerries; Tibor Horváth; Anne Limbourg; Florian Limbourg; Danilo Fliser; Hermann Haller; Helmut Drexler; Ulf Landmesser Journal: Circulation Date: 2007-06-25 Impact factor: 29.690
Authors: Ben J Wu; Robyn G Midwinter; Carlos Cassano; Konstanze Beck; Yutang Wang; Dechaboon Changsiri; Jennifer R Gamble; Roland Stocker Journal: Arterioscler Thromb Vasc Biol Date: 2009-06-18 Impact factor: 8.311
Authors: George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham Journal: Arch Biochem Biophys Date: 2019-08-16 Impact factor: 4.013
Authors: Stephen J Peterson; Joseph I Shapiro; Ellen Thompson; Shailendra Singh; Lu Liu; Jeremy A Weingarten; Kathleen O'Hanlon; Angelica Bialczak; Siddharth R Bhesania; Nader G Abraham Journal: Obesity (Silver Spring) Date: 2019-01 Impact factor: 5.002
Authors: Yossi Issan; Edith Hochhauser; Austin Guo; Katherine H Gotlinger; Ran Kornowski; Dorit Leshem-Lev; Eli Lev; Eyal Porat; Eitan Snir; Carl I Thompson; Nader G Abraham; Michal Laniado-Schwartzman Journal: Prostaglandins Other Lipid Mediat Date: 2013-01-03 Impact factor: 3.072
Authors: Kyeong Mi Kim; Hyun-Ju An; Sang-Hoon Kim; JuHee Kim; Changgon Sim; Jaemin Lee; Sin Hyung Park; Hyun Il Lee; Inseok Jang; Soonchul Lee Journal: Front Cardiovasc Med Date: 2022-05-13
Authors: Nader G Abraham; Komal Sodhi; Anne M Silvis; Luca Vanella; Gaia Favero; Rita Rezzani; Craig Lee; Darryl C Zeldin; Michal L Schwartzman Journal: Hypertension Date: 2014-09-22 Impact factor: 10.190
Authors: Peter A Hosick; Mary Frances Weeks; Michael W Hankins; Kyle H Moore; David E Stec Journal: Int J Mol Sci Date: 2017-03-11 Impact factor: 5.923
Authors: Leandro C Freitas Lima; Valdir de Andrade Braga; Maria do Socorro de França Silva; Josiane de Campos Cruz; Sérgio H Sousa Santos; Matheus M de Oliveira Monteiro; Camille de Moura Balarini Journal: Front Physiol Date: 2015-11-03 Impact factor: 4.566